Literature DB >> 10980832

The ablate-and-pace strategy in atrial fibrillation.

P O'Callaghan1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10980832     DOI： 10.1007/s11886-999-0071-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  4 in total

1.  Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm.

Authors:  H J Marshall; Z I Harris; M J Griffith; R L Holder; M D Gammage
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

2.  Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation.

Authors:  A P Fitzpatrick; H D Kourouyan; A Siu; R J Lee; M D Lesh; L M Epstein; J C Griffin; M M Scheinman
Journal:  Am Heart J       Date:  1996-03       Impact factor: 4.749

3.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.

Authors:  M Brignole; C Menozzi; L Gianfranchi; G Musso; R Mureddu; N Bottoni; G Lolli
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

4.  Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study.

Authors:  M Brignole; L Gianfranchi; C Menozzi; P Alboni; G Musso; M G Bongiorni; M Gasparini; A Raviele; G Lolli; N Paparella; S Acquarone
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.